Edmond de Rothschild Holding’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-50,000
| Closed | -$59.5K | – | 632 |
|
|
2024
Q2 | $59.5K | Hold |
50,000
| – | – | ﹤0.01% | 545 |
|
|
2024
Q1 | $90K | Hold |
50,000
| – | – | ﹤0.01% | 515 |
|
|
2023
Q4 | $44K | Hold |
50,000
| – | – | ﹤0.01% | 573 |
|
|
2023
Q3 | $36.8K | Hold |
50,000
| – | – | ﹤0.01% | 581 |
|
|
2023
Q2 | $63K | Hold |
50,000
| – | – | ﹤0.01% | 551 |
|
|
2023
Q1 | $36.2K | Hold |
50,000
| – | – | ﹤0.01% | 617 |
|
|
2022
Q4 | $26.4K | Hold |
50,000
| – | – | ﹤0.01% | 699 |
|
|
2022
Q3 | $42K | Hold |
50,000
| – | – | ﹤0.01% | 675 |
|
|
2022
Q2 | $55K | Hold |
50,000
| – | – | ﹤0.01% | 653 |
|
|
2022
Q1 | $63K | Hold |
50,000
| – | – | ﹤0.01% | 649 |
|
|
2021
Q4 | $80K | Hold |
50,000
| – | – | ﹤0.01% | 651 |
|
|
2021
Q3 | $163K | Hold |
50,000
| – | – | ﹤0.01% | 565 |
|
|
2021
Q2 | $316K | Hold |
50,000
| – | – | 0.01% | 477 |
|
|
2021
Q1 | $106K | Buy |
+50,000
| New | +$106K | ﹤0.01% | 554 |
|